These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1354810)

  • 1. Lack of activity of zidovudine against Ureaplasma urealyticum and Mycoplasma hominis.
    Madoff S; Ferraro MJ; Merrill DP; Hirsch MS
    Lancet; 1992 Aug; 340(8817):484. PubMed ID: 1354810
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
    Rumpianesi F; Morandotti G; Sperning R; Satta G; Cevenini R
    J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum.
    Dósa E; Nagy E; Falk W; Szöke I; Ballies U
    J Antimicrob Chemother; 1999 Apr; 43(4):575-8. PubMed ID: 10350390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.
    Wang QY; Li RH; Zheng LQ; Shang XH
    J Microbiol Immunol Infect; 2016 Jun; 49(3):359-62. PubMed ID: 25081985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital.
    Skiljevic D; Mirkov D; Vukicevic J
    Indian J Dermatol Venereol Leprol; 2016; 82(1):37-41. PubMed ID: 26728808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro antimycoplasmal activity of flurithromycin.
    Furneri PM; Bisignano G; Cerniglia G; Tempera G; Nicoletti G
    J Antimicrob Chemother; 1995 Jan; 35(1):161-5. PubMed ID: 7768764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence and drug tolerance of mycoplasma in patients with urogenital inflammation].
    Yan ZH; Zhou M; Zhang W; Zhang DL
    Zhonghua Nan Ke Xue; 2003 Nov; 9(8):599-600, 603. PubMed ID: 14689895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Antibiotic Susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in Pregnant Women.
    Lee MY; Kim MH; Lee WI; Kang SY; Jeon YL
    Yonsei Med J; 2016 Sep; 57(5):1271-5. PubMed ID: 27401661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
    Furneri PM; Bisignano G; Cerniglia G; Nicoletti G; Cesana M; Tempera G
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2651-4. PubMed ID: 7872762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of tetM in Mycoplasma hominis and Ureaplasma urealyticum by PCR: tetM confers resistance to tetracycline but not necessarily to doxycycline.
    Blanchard A; Crabb DM; Dybvig K; Duffy LB; Cassell GH
    FEMS Microbiol Lett; 1992 Aug; 74(2-3):277-81. PubMed ID: 1526460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
    Farkas B; Ostorházi E; Pónyai K; Tóth B; Adlan E; Párducz L; Marschalkó M; Kárpáti S; Rozgonyi F
    Orv Hetil; 2011 Oct; 152(42):1698-702. PubMed ID: 21979223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis.
    Vargović M; Pasini M; Papić N; Andrašević S; Markotić A; Butić I; Škerk V
    Sex Transm Infect; 2014 Feb; 90(1):69. PubMed ID: 24366778
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
    Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
    Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women.
    Bayraktar MR; Ozerol IH; Gucluer N; Celik O
    Int J Infect Dis; 2010 Feb; 14(2):e90-5. PubMed ID: 19515594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and antibiotic susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Xi'an, China.
    Zeng XY; Xin N; Tong XN; Wang JY; Liu ZW
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1941-1947. PubMed ID: 27530531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.
    Ullmann U; Schubert S; Krausse R
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():33-6. PubMed ID: 10404335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas.
    Hannan PC; Woodnutt G
    J Antimicrob Chemother; 2000 Mar; 45(3):367-9. PubMed ID: 10702559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years.
    De Francesco MA; Caracciolo S; Bonfanti C; Manca N
    J Infect Chemother; 2013 Aug; 19(4):621-7. PubMed ID: 23192735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
    Cohen MA; Huband MD
    J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Waites KB; Crabb DM; Xiao L; Duffy LB
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.